Skip to main content

Table 3 Red blood cell membrane fatty acid composition of normo- and dyslipidemic men at baseline (t 0 ) and after supplementation with fish oil over twelve weeks (t 12 )

From: Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men

 

Normolipidemic (n = 9)

Dyslipidemic (n = 7)

Fatty acid [%] *

t0

t12

t0

t12

C20:4n-6 (AA)

16.04 ± 0.80 a

13.09 ± 0.63 #

12.71 ± 2.52 a

11.56 ± 1.58

C20:5n-3 (EPA)

0.85 ± 0.20

3.85 ± 0.64 #

1.02 ± 0.43

3.46 ± 0.68 #

C22:6n-3 (DHA)

4.47 ± 0.67

6.92 ± 0.81 #

3.85 ± 1.45

6.46 ± 0.77 #

SFA

36.42 ± 1.46

39.24 ± 1.25 #

36.74 ± 1.78

39.24 ± 1.74

MUFA

17.98 ± 1.64 a

17.20 ± 1.02 b

22.15 ± 3.44 a

19.03 ± 1.18 b#

PUFA

44.59 ± 2.37 a

42.98 ± 1.16 #

40.13 ± 2.90 a

41.11 ± 1.71

n-3 PUFA

7.90 ± 0.94

14.71 ± 1.45 #

7.33 ± 2.04

13.53 ± 1.49 #

n-6 PUFA

36.68 ± 2.09 a

28.27 ± 1.39 #

32.80 ± 2.04 a

27.58 ± 1.86 #

Omega-3 index

5.32 ± 0.74

10.77 ± 1.10 #

4.87 ± 1.83

9.92 ± 1.34 #

  1. * percentage of total fatty acids.
  2. a t0 values of normolipidemic subjects vs. t0 values of dyslipidemic subjects were tested by student’s t-test; p < 0.05.
  3. b t12 values of normolipidemic subjects vs. t12 values of dyslipidemic subjects were tested by student’s t-test; p < 0.05.
  4. # t0 values vs. t12 values were tested by student’s paired t-test; p < 0.05.